1 / 30

US TRENDS IN REFRACTIVE SURGERY: 2003 ASCRS SURVEY

This survey analyzes the trends in refractive surgery among ASCRS and ISRS/AAO members in the US. It covers various procedures, instruments, and post-operative practices. Results show the preferred surgery for different refractive errors, the use of wavefront-guided custom ablations, and the market for post-operative medications. Full survey results can be found on the ASCRS and Duffey Laser websites.

elinc
Télécharger la présentation

US TRENDS IN REFRACTIVE SURGERY: 2003 ASCRS SURVEY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. US TRENDS IN REFRACTIVE SURGERY: 2003 ASCRS SURVEY Richard J. Duffey, MD David Leaming, MD San Diego: May 3, 2004

  2. 2003 ASCRS SURVEY • Sept. mailing to 5000 U.S. members of ASCRS • 509 responses representing 11% of the U.S. ASCRS membership • Seventh year of refractive data collection allowing analysis and comparison of trends amongst ASCRS U.S. surgeons • RK, AK, Cat/LRI, PRK, LASIK, LASEK, ICR, LTK, CK, P-IOL, CLE, SE, excimers, microkert., topogr., pupillometry, wavefront DUFFEY 2004

  3. 2003 ISRS SURVEY • Sept. mailing to 1098 U.S. members of the newly combined ISRS/AAO • 135 responses analyzed by Oct 15 for 12.5% of the U.S. ISRS/AAO membership • Seventh year of refractive data collection allowing an analysis of trends in US • RK, AK/LRI, PRK, LASIK, LASEK, ICR, LTK, CK, CLE, P-IOL, SE, excimer lasers, microker., topo., coman., postop meds, charges, pupillometry, custom abl., etc.

  4. > 5 CASES / MONTH DUFFEY 2004

  5. > 25 CASES / MONTH DUFFEY 2004

  6. > 75 CASES / MONTH DUFFEY 2004

  7. PREFERRED SURGERY FOR 30 yo -3.00 DIOPTER MYOPE DUFFEY 2004

  8. PREFERRED SURGERY FOR 30 yo -7.00 DIOPTER MYOPE DUFFEY 2004

  9. PREFERRED SURGERY FOR 30 yo -12.00 DIOPTER MYOPE DUFFEY 2004

  10. PREFERRED SURGERY FOR 45 yo +1.00 D HYPEROPE DUFFEY 2004

  11. PREFERRED SURGERY FOR 45 yo +3.00 D HYPEROPE DUFFEY 2004

  12. PREFERRED SURGERY FOR 45 yo +5.00 D HYPEROPE DUFFEY 2004

  13. HAD REFRACTIVE SURGERY PERFORMED ON YOURSELF DUFFEY 2004

  14. SURGEON WILLING TO DO BILATERAL AT SAME VISIT DUFFEY 2004

  15. PRESENT and FUTURE PRACTICE PLANS DUFFEY 2004

  16. TOPOGRAPHY UNIT OWNED DUFFEY 2004

  17. MICROKERATOME USED MOST DUFFEY 2004

  18. EXCIMER USED MOST DUFFEY 2004

  19. Pupil Gauge Instrument Use DUFFEY 2004

  20. Wavefront Analyzer DUFFEY 2004

  21. Wavefront-Guided Custom Ablations in Your Practice DUFFEY 2004

  22. Anticipated Value of Custom Laser Ablations DUFFEY 2004

  23. Anticipated/Real Increase in Charge to Patient for Custom Wavefront Laser Treatment DUFFEY 2004

  24. Preferred Surgery for Presbyopia DUFFEY 2004

  25. Post-Op Antibiotic DUFFEY 2004

  26. Post-Op Anti-inflammatory DUFFEY 2004

  27. ’03 ASCRS SURVEY CONCLUSIONS • LASIK dominates between -8D and +3D. • Bilateral LASIK same O.R. visit is SOC. • P-IOL or Wait for high myopes. • CLE for high hyperopes. • LASIK, LASEK, CLE, P-IOL, PRK, CK all with apparent bright futures. • RK, ICR, LTK, and SE dead or dying. DUFFEY 2004

  28. Conclusions continued... • VisX at 2:1 over all other lasers. • Pupillometry 55:45 IR instrument over card • Wavefront custom ablations have gained rapid acceptance into practice with 69% stating moderate to extreme value added. • 55% use wavefront analyzers. • 52% perform custom ablations. DUFFEY 2004

  29. Conclusions continued... • Surgeons are charging $300-$500 more per eye for custom ablations • Orbscan is not S.O.C. require. for refrac. sx • Monovision is still “choice” for presbyopia • Fourth generation fluoroquinolones have overtaken the post-refractive surg. market. • PF and FML lead post-op steroids/anti-inflammatories. DUFFEY 2004

  30. Thanks to ASCRS leadership for their support and for your participation in the 2003 Survey We look forward to your responses in the 2004 survey this autumn. Complete results at www.ascrs.org and at www.duffeylaser.com

More Related